30 Day FDA and ICH Drug Development Regulations - Day 29 Ethical Considerations episode artwork

EPISODE · Jan 29, 2025 · 21 MIN

30 Day FDA and ICH Drug Development Regulations - Day 29 Ethical Considerations

from Cannabinoid and Psychedelic Pharmacology and Drug Development

Uncover the intricate ethical landscape behind every pill in your medicine cabinet. This episode takes you through the unseen journey of drug development, from phase one trials and informed consent to global manufacturing and the delicate balance between safety, access, and equity. Explore how international guidelines, rigorous oversight, and cutting-edge science work together to address impurities, ensure fairness, and protect patient health. A thought-provoking look at the dedication and responsibility shaping modern medicine.

Episode metadata supplied by the publisher feed · Published Jan 29, 2025

Embed this episode

NOW PLAYING

30 Day FDA and ICH Drug Development Regulations - Day 29 Ethical Considerations

0:00 21:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 21 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 29, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!